The companies have acquired pulsed field ablation devices in recent years, but one surgeon told analysts he prefers Boston Scientific’s device as it doesn’t require general anesthesia, leading to faster patient turnaround.
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its algorithm intended to detect suspected abdominal aortic aneurysm (AAA).
La sostenibilidad es la capacidad del medio ambiente para resistir el impacto humano. Para satisfacer sus crecientes necesidades, la producción destruye cada vez más recursos naturales. Y la cuestión del respeto al medio ambiente y la reducción del consumo es cada d&iacut …
Sostenibilidad medioambiental con códigos QR: ¡por un futuro más verde! Read More »
NanoVibronix, Inc today announced it has filed a new provisional patent application with the United States Patent and Trademark Office.
NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra Read More »
Ichnos Sciences Inc. today announced the company has been granted orphan drug designation (ODD) by the U.S. Food and Drug Administration (FDA) for its first-in-class biparatopic 2+1 BEAT® bispecific antibody targeting CD38 and CD47 for the treatment of relapsed/refractory multiple myeloma (MM).
Ankyra Therapeutics, a biotech company developing targeted immune activating agents for the treatment of cancer, today announced the appointment of Stephen Gorgol as chief financial officer.
Direct Biologics, LLC announced it has dosed the first patient in its Phase 1 clinical trial evaluating ExoFlo ™ for the treatment of patients with medically refractory Crohn’s disease.
Vivani Medical, Inc., an innovative, clinical-stage biopharmaceutical company that develops novel, long-term therapeutic implants, announced the filing of a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission for the proposed initial public offering of Cortigent, Inc.
En este Short os hablamos de un antiguo planeta que podría haber evitado que en la Tierra proliferara la vida. …
El planeta que podría haber acabado con la vida de la Tierra Read More »
Zura Bio Limited announced the closing of its business combination with JATT Acquisition Corp, a special purpose acquisition company, on March 20, 2023.
Zura Bio Limited Announces Closing of Business Combination with JATT Acquisition Corp Read More »
